Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Awards
June 17, 2026
Finalists for the Impact, Innovation and Applied Research Award
TransBIOTech, in partnership with 9bio Therapeutics, are finalists for the ADRIQ Impact, Innovation and Applied Research Award.
Publications & Expertise
April 15, 2026
Scientific Presentation
Poster presented by Carole-Ann Huppé, PhD, MBA, pharmacology researcher, at the annual conference of the Canadian Thoracic Society in Calgary (AB) on April 16-18, 2026
Collaborations
March 12, 2026
Feldan Therapeutics Partners with TransBIOTech for an NSERC-Funded Project
Feldan Therapeutics is collaborating with TransBIOTech on a project funded by NSERC with up to $450,000 to accelerate the development of innovative intralesional treatments. This non-dilutive funding will support Feldan's three-year development of novel therapeutic approaches targeting tumor lesions through intralesional injections. TransBIOTech will undertake the necessary in vivo experiments to advance this research.
